Cite
TCTAP A-100 Clinical Outcome of Drug-Eluting Stent Implantation for Diabetic Patients with Femoropopliteal Disease in Comparison with Bare Metal Stent
MLA
Masahiro Yamawaki, et al. “TCTAP A-100 Clinical Outcome of Drug-Eluting Stent Implantation for Diabetic Patients with Femoropopliteal Disease in Comparison with Bare Metal Stent.” Journal of the American College of Cardiology, vol. 65, May 2015, pp. S53–54. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....14f524ddfd1af1b83ed75f3d78657be6&authtype=sso&custid=ns315887.
APA
Masahiro Yamawaki, Masatsugu Nakano, Motoharu Araki, Shinsuke Mori, Takahiro Tokuda, Yasunari Sakamoto, Hiroya Takafuji, Hiroshi Ishimori, Keisuke Hirano, Masakazu Tsutsumi, Takuro Takama, Toshiya Muramatsu, Yohsuke Honda, & Norihiro Kobayashi. (2015). TCTAP A-100 Clinical Outcome of Drug-Eluting Stent Implantation for Diabetic Patients with Femoropopliteal Disease in Comparison with Bare Metal Stent. Journal of the American College of Cardiology, 65, S53–S54.
Chicago
Masahiro Yamawaki, Masatsugu Nakano, Motoharu Araki, Shinsuke Mori, Takahiro Tokuda, Yasunari Sakamoto, Hiroya Takafuji, et al. 2015. “TCTAP A-100 Clinical Outcome of Drug-Eluting Stent Implantation for Diabetic Patients with Femoropopliteal Disease in Comparison with Bare Metal Stent.” Journal of the American College of Cardiology 65 (May): S53–54. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....14f524ddfd1af1b83ed75f3d78657be6&authtype=sso&custid=ns315887.